Impact of COVID-19 on Clinical Frailty Scale – a multicentre prospective cohort study.

S. Guler (Bern, Switzerland), I. Müller (Bern, Switzerland), M. Mancinetti (Fribourg, Switzerland), P. Bridevaux (Sion, Switzerland), M. Brutsche (St. Gallen, Switzerland), C. Clarenbach (Zürich, Switzerland), C. Garzoni (Lugano , Switzerland), A. Lenoir (Lausanne, Switzerland), B. Naccini (Lugano , Switzerland), S. Ott (Basel, Switzerland), L. Piquilloud (Lausanne, Switzerland), M. Prella (Lausanne, Switzerland), Y. Que (Lausanne, Switzerland), P. Soccal (Geneva, Switzerland), C. Von Garner (Lausanne, Switzerland), T. Geiser (Bern, Switzerland), M. Funke-Chambour (Bern, Switzerland)

Source: Virtual Congress 2021 – Chronic COVID - 19
Session: Chronic COVID - 19
Session type: Oral Presentation
Number: 84

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Guler (Bern, Switzerland), I. Müller (Bern, Switzerland), M. Mancinetti (Fribourg, Switzerland), P. Bridevaux (Sion, Switzerland), M. Brutsche (St. Gallen, Switzerland), C. Clarenbach (Zürich, Switzerland), C. Garzoni (Lugano , Switzerland), A. Lenoir (Lausanne, Switzerland), B. Naccini (Lugano , Switzerland), S. Ott (Basel, Switzerland), L. Piquilloud (Lausanne, Switzerland), M. Prella (Lausanne, Switzerland), Y. Que (Lausanne, Switzerland), P. Soccal (Geneva, Switzerland), C. Von Garner (Lausanne, Switzerland), T. Geiser (Bern, Switzerland), M. Funke-Chambour (Bern, Switzerland). Impact of COVID-19 on Clinical Frailty Scale – a multicentre prospective cohort study.. 84

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical Assessment of Glycopyrronium in COPD phenotypes and ACOS: Prospective, case control, observational study
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study
Source: ERJ Open Res, 8 (1) 00552-2021; 10.1183/23120541.00552-2021
Year: 2022



Patient-reported outcome measures after COVID-19: a prospective cohort study
Source: Eur Respir J, 56 (5) 2003276; 10.1183/13993003.03276-2020
Year: 2020



Effectiveness of treatments for severe sepsis: a prospective multicentre observational study in Spanish ICUs
Source: Annual Congress 2009 - Severe sepsis and multiple organ failure
Year: 2009


Validation of the Sarcoidosis Diagnostic Score in a multinational study
Source: International Congress 2019 – Granulomatous disorders: from bench to bedside
Year: 2019



Asthma phenotypes in Turkey: A multicenter study
Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Year: 2012


Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study
Source: Eur Respir J, 59 (2) 2101341; 10.1183/13993003.01341-2021
Year: 2022



Benefits of pulmonary rehabilitation in COVID-19 – a prospective observational cohort study
Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19
Year: 2021


An Italian, observational, multicenter trial in female COPD patients: Preliminary data on the women reality in the MISTRAL study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019
Year: 2020



Incidence and prevalence of Systemic Sclerosis-associated Interstitial Lung Disease in a multicenter prospective cohort study.
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020


Assessment of the association between asthma and malignancy: a population-based retrospective matched cohort study
Source: Annual Congress 2009 - Epidemiology of COPD and infectious lung diseases
Year: 2009


Prospective cohort study of cured meat intake and asthma symptom score in the EGEA study
Source: International Congress 2015 – New observations in respiratory epidemiology
Year: 2015

Clinical, radiological and functional outcomes in patients with COVID-19 pneumonia: A prospective observational study
Source: Virtual Congress 2021 – Imaging in COVID-19
Year: 2021


Late Breaking Abstract - 1-year radiological, functional and quality-of-life outcomes in patients with SARS-CoV-2 pneumonia: A prospective observational study.
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021



Plasma levels of acute phase proteins in patients from the multicenter longitudinal French Cohort in Lung Transplantation (COLT): a pilot study
Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Year: 2020




Etiology and clinical characteristics of bronchiectasis in Taiwan: a multi-center cohort study
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019


Protocol for the EARCO Registry: a pan-European observational study in patients with a1-antitrypsin deficiency
Source: ERJ Open Res, 6 (1) 00181-2019; 10.1183/23120541.00181-2019
Year: 2020



Characteristics of COPD patients from primary care enrolled in a prospective multicenter cohort study
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010


Late Breaking Abstract - Long-term safety of pirfenidone in a real-world setting: final results from the prospective, observational PASSPORT registry
Source: International Congress 2017 – Late-breaking findings in pulmonary diseases
Year: 2017